The Latest Cardiac and Vascular News
KYOTO, Japan, Nov. 24, 2020 /PRNewswire/ — OMRON Healthcare Co., Ltd. announced on November 24 additional investment into AliveCor by its parent company, OMRON Corporation, as part of $65 million series E funding for the leader in AI-based personal electrocardiogram (ECG) technology. OMRON led this round of investment, reinforcing the cross-company collaboration that began in 2017. The companies continue to […]
OXFORD, England, Dec. 7, 2020 /PRNewswire/ — GEN inCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease announces today the appointment of Paul Foulger as Chief Financial Officer to the Company. Paul Foulger is an experienced CFO with a proven, demonstrable track record in the Biotech industry for both […]
Contour Therapeutics Brings Together Leaders with Extensive Cardiovascular, Genetics and Drug Development Expertise Partnership Focused on Delivering Targeted Therapies for Genetically Defined Cardiovascular Diseases PALO ALTO, Calif. and SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) and Maze Therapeutics today announced the establishment of a joint venture, Contour Therapeutics, focused […]
– Special Meeting of Stockholders Scheduled for January 26, 2021 Seeking Authorization to Potentially Effectuate a Discretionary Reverse Stock Split Prior to January 26, 2022 – – Company’s Proposal to Stockholders Intended to Enhance Appeal of Common Stock to Institutional Investors, Position its Common Stock for Potential Eligibility for Inclusion in Certain Biotechnology and Pharmaceutical Trading Indices and for Potential Inclusion on the NYSE “Big Board” or NASDAQ Global Market – BEDMINSTER, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), […]
Funding to support development of the first reversible thrombolytic therapy for acute ischemic stroke COLUMBUS, Ohio–(BUSINESS WIRE)–Basking Biosciences, Inc. (Basking), a privately-held biopharmaceutical company developing a next generation treatment for acute ischemic stroke (AIS) announced an initial closing of a $5.4M Seed Series financing. The investor syndicate includes Rev1 Ventures, […]
NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Boston Scientific Corporation (NYSE: BSX) between April 24, 2019 to November 16, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages […]
SUNNYVALE, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the appointment of Kevin Ballinger to the company’s Board of Directors. Simultaneously, the company also announced the resignation of current board […]
STOCKHOLM, Dec. 4, 2020 /PRNewswire/ — Regarding the acquisition of the assets from Vascular Simulations Inc 571,974 shares have been issued at a subscription price of SEK 86.16 and regarding the acquisition of the assets from EQIP Inc, 9,469 shares have been issued at a subscription price of SEK 84.28. The total number of shares […]
– OMRON reinforces its involvement with AliveCor with E-series investment and strengthens the alliance between the companies for the remote management of cardiovascular conditions KYOTO, Japan, Dec.4, 2020 / PRNewswire / – OMRON Healthcare Co., Ltd. announced on November 24 the additional investment in AliveCor by its parent company, […]
Steven Brooks, M.D., MBA, FACC – Appointed EVP of Medical and Regulatory Affairs, Chief Medical Officer Donald Very, Ph.D. – Appointed EVP, Research & Development William Hearl, Ph.D. – Named Independent Member of Board of Directors JUPITER, Fla., Dec. 4, 2020 /PRNewswire/ — Marizyme, Inc. (OTCQB: MRZM), a publicly traded global biotechnology company developing products […]
